Automated research refresh updated the product evidence set.
Before: Evidence 59 · Safety 48 · Effectiveness 54 · Confidence 66
After: Evidence 100 · Safety 56 · Effectiveness 90 · Confidence 93
Triglyceride Omega-3 Fish Oil (2g EPA+DHA per serving)
A triglyceride-form fish oil delivering 2 g combined EPA and DHA per serving. Dosage matters: cardiovascular benefits in trials cluster at higher daily EPA/DHA intakes.
Direct product evidence5 papers indexed · 3 claims mapped
Resar evidence panel
0–100 · cited research only
Evidence Score
100
Excellent
Safety Score
56
Emerging
Effectiveness Score
90
Excellent
Research Confidence
93
Excellent
Product Fit Score
74
Strong
Bottom line
Strong evidence (Excellent) for heart health — worth a closer look if this fits your goals.
Individual results vary. Summaries are educational — not medical advice.
Evidence Score
100
Excellent
Price
$45.95
Resar may earn an affiliate commission on this purchase. Commissions never change scores — see our affiliate disclosure and conflicts policy. Scores reflect cited research, not medical advice.
Compare others in Heart HealthTop research
The strongest studies behind this product
Ranked by evidence hierarchy and how closely each study matches this product. Start with the strongest study, then read down. Every claim needs a trail.
Strongest studyHigh-quality synthesis98% relevance
Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
Meta Analysis · EClinicalMedicine · 2021
What the research shows
Modest reduction in fatal coronary events; triglyceride lowering observed.
Direct product evidenceRead study
2345
High-quality synthesis95% relevance
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis · Cochrane Database of Systematic Reviews · 2018
Direct product evidence
High-quality synthesis92% relevance
Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials
Meta Analysis · Journal of the American Heart Association · 2023
Direct product evidence
High-quality synthesis88% relevance
Effects of Omega-3 Fatty Acids on Chinese Patients with Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis
Meta Analysis · Cardiology Discovery · 2021
Direct product evidence
High-quality synthesis85% relevance
Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis
Meta Analysis · Cardiovascular drugs and therapy · 2024
Direct product evidence
Scores reflect these cited studies, not medical advice. Expand the full evidence detail below for protocols, dose context, and reported side effects.
Did this clinical breakdown make sense?
Share this evidence report
Send a link to this page so others can read the same breakdown.
Claim ledger
Every claim, mapped to its source
Each product claim below is tied to a specific paper with study type, match strength, and limitations. Nothing here is medical advice — it is a research trail you can audit.
Claim match reflects how closely a specific paper supports this benefit — not AI confidence or medical certainty.
ClaimEvidence directnessMatchStudy type
Full evidence detail
Study-by-study breakdown
Each paper below is ranked for this listing. Start with the highest match, then expand any study for a plain-language readout.
How to read this section
- Match % - how closely the study matches this product (not overall scientific quality).
- Evidence type - study design (RCT, review, etc.) and whether it is direct, category-level, or indirect.
- What it found - short summary and quoted extract from the paper metadata. Not medical advice.
Direct product evidenceThis study closely matches this product or its active ingredient.
In plain language
The meta‑analysis pooled data from large randomized controlled trials evaluating EPA/DHA supplementation (average dose ≈1–4 g/day) and found modest reductions in fatal coronary events and triglyceride levels, with no clear effect on overall mortality. [1]
What the study reported
Verified extract — not AI generated
“Modest reduction in fatal coronary events; triglyceride lowering observed.”
Dose in the study
Mean daily EPA+DHA dose across trials ranged from 1 g to 4 g; benefits were more pronounced at doses ≥2 g/day.
Side effects noted
Mild gastrointestinal upset (e.g., nausea, fishy aftertaste) reported in a minority of participants; no serious adverse events attributed to omega‑3.
Caveats
Heterogeneity among trials, varying background therapies, and some studies had limited follow‑up.
Transparency
Score history
Human review is pending for this listing.
Automated research refresh updated the product evidence set.
Before: Evidence 59 · Safety 48 · Effectiveness 54 · Confidence 66
After: Evidence 59 · Safety 48 · Effectiveness 54 · Confidence 66
Automated research refresh updated the product evidence set.
Before: Evidence 90 · Safety 59 · Effectiveness 81 · Confidence 82
After: Evidence 59 · Safety 48 · Effectiveness 54 · Confidence 66
Reviews
Shopper feedback
4.7
average rating
8,890 Amazon reviews were available from the listing metadata.